Logo image of CBRE

CBRE GROUP INC - A (CBRE) Stock Fundamental Analysis

USA - NYSE:CBRE - US12504L1098 - Common Stock

151.83 USD
-0.82 (-0.54%)
Last: 11/10/2025, 8:04:00 PM
151.83 USD
0 (0%)
After Hours: 11/10/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CBRE. CBRE was compared to 63 industry peers in the Real Estate Management & Development industry. Both the profitability and the financial health of CBRE get a neutral evaluation. Nothing too spectacular is happening here. CBRE is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make CBRE suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CBRE was profitable.
In the past year CBRE had a positive cash flow from operations.
In the past 5 years CBRE has always been profitable.
Each year in the past 5 years CBRE had a positive operating cash flow.
CBRE Yearly Net Income VS EBIT VS OCF VS FCFCBRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.30%, CBRE belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
CBRE's Return On Equity of 14.39% is amongst the best of the industry. CBRE outperforms 93.65% of its industry peers.
CBRE's Return On Invested Capital of 6.76% is amongst the best of the industry. CBRE outperforms 85.71% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CBRE is in line with the industry average of 6.31%.
Industry RankSector Rank
ROA 4.3%
ROE 14.39%
ROIC 6.76%
ROA(3y)5.07%
ROA(5y)5.54%
ROE(3y)13.78%
ROE(5y)14.7%
ROIC(3y)7.46%
ROIC(5y)7.57%
CBRE Yearly ROA, ROE, ROICCBRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of CBRE (3.12%) is better than 71.43% of its industry peers.
CBRE's Profit Margin has declined in the last couple of years.
CBRE has a Operating Margin of 4.18%. This is in the better half of the industry: CBRE outperforms 60.32% of its industry peers.
CBRE's Operating Margin has declined in the last couple of years.
CBRE has a Gross Margin of 19.22%. This is comparable to the rest of the industry: CBRE outperforms 44.44% of its industry peers.
In the last couple of years the Gross Margin of CBRE has declined.
Industry RankSector Rank
OM 4.18%
PM (TTM) 3.12%
GM 19.22%
OM growth 3Y-8.91%
OM growth 5Y-5.18%
PM growth 3Y-25.78%
PM growth 5Y-12.79%
GM growth 3Y-4.04%
GM growth 5Y-2.06%
CBRE Yearly Profit, Operating, Gross MarginsCBRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

CBRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CBRE has less shares outstanding
Compared to 5 years ago, CBRE has less shares outstanding
CBRE has a worse debt/assets ratio than last year.
CBRE Yearly Shares OutstandingCBRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CBRE Yearly Total Debt VS Total AssetsCBRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

CBRE has an Altman-Z score of 3.47. This indicates that CBRE is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.47, CBRE is in the better half of the industry, outperforming 74.60% of the companies in the same industry.
The Debt to FCF ratio of CBRE is 5.36, which is a neutral value as it means it would take CBRE, 5.36 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CBRE (5.36) is better than 73.02% of its industry peers.
A Debt/Equity ratio of 0.84 indicates that CBRE is somewhat dependend on debt financing.
CBRE has a Debt to Equity ratio (0.84) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 5.36
Altman-Z 3.47
ROIC/WACC0.78
WACC8.71%
CBRE Yearly LT Debt VS Equity VS FCFCBRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

CBRE has a Current Ratio of 1.13. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.13, CBRE is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
CBRE has a Quick Ratio of 1.13. This is a normal value and indicates that CBRE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CBRE (1.13) is worse than 63.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
CBRE Yearly Current Assets VS Current LiabilitesCBRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.41% over the past year.
Measured over the past 5 years, CBRE shows a small growth in Earnings Per Share. The EPS has been growing by 6.61% on average per year.
The Revenue has grown by 14.61% in the past year. This is quite good.
The Revenue has been growing by 8.40% on average over the past years. This is quite good.
EPS 1Y (TTM)43.41%
EPS 3Y-1.88%
EPS 5Y6.61%
EPS Q2Q%34.17%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y8.83%
Revenue growth 5Y8.4%
Sales Q2Q%13.52%

3.2 Future

CBRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.98% yearly.
The Revenue is expected to grow by 9.02% on average over the next years. This is quite good.
EPS Next Y26.21%
EPS Next 2Y20.87%
EPS Next 3Y19.27%
EPS Next 5Y17.98%
Revenue Next Year14.61%
Revenue Next 2Y11.97%
Revenue Next 3Y10.81%
Revenue Next 5Y9.02%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CBRE Yearly Revenue VS EstimatesCBRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B
CBRE Yearly EPS VS EstimatesCBRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 25.39, the valuation of CBRE can be described as expensive.
Based on the Price/Earnings ratio, CBRE is valued a bit cheaper than the industry average as 74.60% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CBRE to the average of the S&P500 Index (26.28), we can say CBRE is valued inline with the index average.
The Price/Forward Earnings ratio is 20.34, which indicates a rather expensive current valuation of CBRE.
CBRE's Price/Forward Earnings ratio is rather cheap when compared to the industry. CBRE is cheaper than 82.54% of the companies in the same industry.
CBRE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 33.61, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.39
Fwd PE 20.34
CBRE Price Earnings VS Forward Price EarningsCBRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBRE indicates a somewhat cheap valuation: CBRE is cheaper than 69.84% of the companies listed in the same industry.
CBRE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CBRE is cheaper than 73.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 33.15
EV/EBITDA 19.24
CBRE Per share dataCBRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBRE has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CBRE's earnings are expected to grow with 19.27% in the coming years.
PEG (NY)0.97
PEG (5Y)3.84
EPS Next 2Y20.87%
EPS Next 3Y19.27%

0

5. Dividend

5.1 Amount

CBRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CBRE GROUP INC - A

NYSE:CBRE (11/10/2025, 8:04:00 PM)

After market: 151.83 0 (0%)

151.83

-0.82 (-0.54%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-23 2025-10-23/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners97.76%
Inst Owner Change-0.26%
Ins Owners0.52%
Ins Owner Change-0.03%
Market Cap45.18B
Revenue(TTM)39.33B
Net Income(TTM)1.23B
Analysts81.05
Price Target182.84 (20.42%)
Short Float %1.14%
Short Ratio2.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.25%
Min EPS beat(2)7.92%
Max EPS beat(2)8.58%
EPS beat(4)4
Avg EPS beat(4)7.29%
Min EPS beat(4)2.25%
Max EPS beat(4)10.42%
EPS beat(8)8
Avg EPS beat(8)8.93%
EPS beat(12)12
Avg EPS beat(12)8.14%
EPS beat(16)14
Avg EPS beat(16)8.73%
Revenue beat(2)1
Avg Revenue beat(2)0.18%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)1.13%
Revenue beat(4)1
Avg Revenue beat(4)-0.61%
Min Revenue beat(4)-1.96%
Max Revenue beat(4)1.13%
Revenue beat(8)3
Avg Revenue beat(8)-0.11%
Revenue beat(12)7
Avg Revenue beat(12)0.83%
Revenue beat(16)8
Avg Revenue beat(16)0.09%
PT rev (1m)6.63%
PT rev (3m)11.4%
EPS NQ rev (1m)1.21%
EPS NQ rev (3m)3.66%
EPS NY rev (1m)2.54%
EPS NY rev (3m)5.86%
Revenue NQ rev (1m)0.95%
Revenue NQ rev (3m)0.5%
Revenue NY rev (1m)1.78%
Revenue NY rev (3m)1.9%
Valuation
Industry RankSector Rank
PE 25.39
Fwd PE 20.34
P/S 1.15
P/FCF 33.15
P/OCF 26.92
P/B 5.29
P/tB N/A
EV/EBITDA 19.24
EPS(TTM)5.98
EY3.94%
EPS(NY)7.46
Fwd EY4.92%
FCF(TTM)4.58
FCFY3.02%
OCF(TTM)5.64
OCFY3.71%
SpS132.17
BVpS28.68
TBVpS-0.99
PEG (NY)0.97
PEG (5Y)3.84
Graham Number62.12
Profitability
Industry RankSector Rank
ROA 4.3%
ROE 14.39%
ROCE 9.44%
ROIC 6.76%
ROICexc 7.37%
ROICexgc 14.13%
OM 4.18%
PM (TTM) 3.12%
GM 19.22%
FCFM 3.47%
ROA(3y)5.07%
ROA(5y)5.54%
ROE(3y)13.78%
ROE(5y)14.7%
ROIC(3y)7.46%
ROIC(5y)7.57%
ROICexc(3y)8.16%
ROICexc(5y)8.57%
ROICexgc(3y)18.67%
ROICexgc(5y)19.47%
ROCE(3y)9.51%
ROCE(5y)9.85%
ROICexgc growth 3Y-10.49%
ROICexgc growth 5Y-5.25%
ROICexc growth 3Y-6.39%
ROICexc growth 5Y-5.52%
OM growth 3Y-8.91%
OM growth 5Y-5.18%
PM growth 3Y-25.78%
PM growth 5Y-12.79%
GM growth 3Y-4.04%
GM growth 5Y-2.06%
F-Score6
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 5.36
Debt/EBITDA 2.86
Cap/Depr 36.25%
Cap/Sales 0.8%
Interest Coverage 3.96
Cash Conversion 66.77%
Profit Quality 110.99%
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 3.47
F-Score6
WACC8.71%
ROIC/WACC0.78
Cap/Depr(3y)45.67%
Cap/Depr(5y)46.01%
Cap/Sales(3y)0.89%
Cap/Sales(5y)0.91%
Profit Quality(3y)86.59%
Profit Quality(5y)117.01%
High Growth Momentum
Growth
EPS 1Y (TTM)43.41%
EPS 3Y-1.88%
EPS 5Y6.61%
EPS Q2Q%34.17%
EPS Next Y26.21%
EPS Next 2Y20.87%
EPS Next 3Y19.27%
EPS Next 5Y17.98%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y8.83%
Revenue growth 5Y8.4%
Sales Q2Q%13.52%
Revenue Next Year14.61%
Revenue Next 2Y11.97%
Revenue Next 3Y10.81%
Revenue Next 5Y9.02%
EBIT growth 1Y13.34%
EBIT growth 3Y-0.86%
EBIT growth 5Y2.79%
EBIT Next Year58.92%
EBIT Next 3Y25.82%
EBIT Next 5Y18.52%
FCF growth 1Y944.54%
FCF growth 3Y-13.36%
FCF growth 5Y8.54%
OCF growth 1Y280.59%
OCF growth 3Y-10.27%
OCF growth 5Y6.9%

CBRE GROUP INC - A / CBRE FAQ

What is the fundamental rating for CBRE stock?

ChartMill assigns a fundamental rating of 5 / 10 to CBRE.


Can you provide the valuation status for CBRE GROUP INC - A?

ChartMill assigns a valuation rating of 5 / 10 to CBRE GROUP INC - A (CBRE). This can be considered as Fairly Valued.


What is the profitability of CBRE stock?

CBRE GROUP INC - A (CBRE) has a profitability rating of 6 / 10.


Can you provide the financial health for CBRE stock?

The financial health rating of CBRE GROUP INC - A (CBRE) is 5 / 10.